These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15000574)

  • 1. The legal proceeding on the use of genotypic assays for the detection of HIV antiretroviral resistance in Italy: background and rationale for a consensus conference to establish guidelines.
    Ippolito G; Visco-Comandini U; Nicastri E
    Scand J Infect Dis Suppl; 2003; 106():8-11. PubMed ID: 15000574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of genotypic assays for the detection of antiretroviral resistance: a legal proceeding, Rome, 22-23 April 2002.
    Sönnerborg A
    Scand J Infect Dis Suppl; 2003; 106():5. PubMed ID: 15000572
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of genotypic assays for the detection of HIV antiretroviral resistance.
    Nicastri E; Ippolito G
    Scand J Infect Dis Suppl; 2003; 106():24-8. PubMed ID: 15000578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief summary of the legal proceeding.
    Nicastri E
    Scand J Infect Dis Suppl; 2003; 106():105-7. PubMed ID: 15000598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.
    Dianzani F; Frascione E
    Scand J Infect Dis Suppl; 2003; 106():108-9. PubMed ID: 15000599
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic resistance tests in the management of the HIV-infected patient at virological failure.
    Aceti A; Carosi G
    Scand J Infect Dis Suppl; 2003; 106():61-6. PubMed ID: 15000587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.
    Visco-Comandini U; Balotta C
    Scand J Infect Dis Suppl; 2003; 106():75-8. PubMed ID: 15000590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation systems for genotypic drug resistance of HIV-1.
    De Luca A; Antinori A; Di Giambenedetto S; Cingolani A; Colafigli M; Perno CF; Cauda R
    Scand J Infect Dis Suppl; 2003; 106():29-34. PubMed ID: 15000579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The legal proceeding: introduction of the witnesses.
    Nicastri E
    Scand J Infect Dis Suppl; 2003; 106():58-60. PubMed ID: 15000586
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotypic resistance testing.
    Andreoni M
    Scand J Infect Dis Suppl; 2003; 106():35-6. PubMed ID: 15000580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of genotypic resistance to antiretroviral drugs in a cohort of therapy-naive HIV-1-infected Italian patients.
    Re MC; Monari P; Borderi M; Tadolini M; Verucchi G; Vitone F; Spinosa S; La Placa M
    J Acquir Immune Defic Syndr; 2001 Jul; 27(3):315-6. PubMed ID: 11464154
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P; Lazzarin A
    Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel.
    Wegner SA; Brodine SK; Mascola JR; Tasker SA; Shaffer RA; Starkey MJ; Barile A; Martin GJ; Aronson N; Emmons WW; Stephan K; Bloor S; Vingerhoets J; Hertogs K; Larder B
    AIDS; 2000 May; 14(8):1009-15. PubMed ID: 10853983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technologies for measuring HIV-1 drug resistance.
    Schmidt B; Korn K; Walter H
    HIV Clin Trials; 2002; 3(3):227-36. PubMed ID: 12032882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors.
    Peduzzi C; Pierotti P; Venturi G; Romano L; Mazzotta F; Zazzi M
    J Clin Virol; 2002 Jul; 25(1):57-62. PubMed ID: 12126722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.
    Montroni M; Monforte AD
    Scand J Infect Dis Suppl; 2003; 106():79-81. PubMed ID: 15000591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of different systems for interpreting results of genotypic antiretroviral drug resistance tests.
    García F; Palomares JC; Martínez NM; Alvarez M; Suarez S; García F; Rodríguez JM; Quero JH; del Carmen Maroto M
    Antivir Ther; 2003 Jun; 8(3):251-2. PubMed ID: 12924543
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.
    Hirsch MS; Conway B; D'Aquila RT; Johnson VA; Brun-Vézinet F; Clotet B; Demeter LM; Hammer SM; Jacobsen DM; Kuritzkes DR; Loveday C; Mellors JW; Vella S; Richman DD
    JAMA; 1998 Jun; 279(24):1984-91. PubMed ID: 9643863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study.
    Torre D; Tambini R
    HIV Clin Trials; 2002; 3(1):1-8. PubMed ID: 11819179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.